111 Capital’s Boston Scientific BSX Stock Holding History

111 Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	33,011 +16,834	+104%	+$914K	0.24%	92
2026 Q1	$1.02M	Sell	16,177 -4,764	-23%	-$381K	0.25%	78
2025 Q4	$2M	Sell	20,941 -9,776	-32%	-$958K	0.44%	38
2025 Q3	$3M	Buy	+30,717	New	+$3.18M	0.57%	31
2025 Q2	–	Sell	-16,143	Closed	-$1.63M	–	533
2025 Q1	$1.63M	Buy	+16,143	New	+$1.63M	0.31%	66

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

111 Capital's BSX Position: Q2 2026 in Review

111 Capital increased its Boston Scientific (BSX) stake by 104% in Q2 2026, buying an estimated $914K and bringing the position to 33,011 shares worth $1.41M. The position accounts for 0.24% of the portfolio, ranked #92.

111 Capital first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

111 Capital held 33,011 shares of Boston Scientific worth $1.41M as of Q2 2026.
111 Capital bought 16,834 Boston Scientific shares in Q2 2026, an estimated $914K.
Boston Scientific made up 0.24% of 111 Capital's portfolio in Q2 2026, its #92 holding.
111 Capital first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
111 Capital's Boston Scientific position peaked at $3M in Q3 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.